JGene Biotechnology

company

About

JGene Biotechnology is a biotechnology company engaged in the research of gene and cell therapies for tumor treatment.

  • 11 - 50

Details

Last Funding Type
Seed
Industries
Biotechnology,Genetics,Health Care,Life Science
Founded date
Jul 1, 2021
Number Of Employee
11 - 50
Operating Status
Active

JGene Biotechnology is a research and development biotechnology company dedicated to the research and development of universal CAR-NK/T products from iPS. It is hoped that the large-scale production of CAR-NK/T from iPS will provide cancer patients with spot-type, price-friendly, and affordable new immune cell therapy products. Recently received angel round investment.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
JGene Biotechnology has raised a total of — in funding over 2 rounds. Their latest funding was raised on Jan 3, 2023 from a Angel round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 3, 2023 Angel 1 Detail
Feb 21, 2022 Seed 1 Vinno Capital Detail

Investors

Number of Lead Investors
Number of Investors
1
1
JGene Biotechnology is funded by 1 investors. Vinno Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Vinno Capital Angel